IQVIA Analytics Link Ecosystem establishes deep connections across our key data assets.
IQVIA MIDAS® has long been considered the gold standard in market information.
It integrates the breadth and depth of IQVIA's unparalleled data assets, with advanced analytics and deep domain expertise, to provide an extensive view of the global pharmaceutical market.
Join this webinar to review key pharma metrics for 2023, understand the current state of post-pandemic recovery, and explore what lies ahead in 2024.
MIDAS Disease delivers deeper insights into your disease of interest.
It enables you to hyper-segment your market and your competitive landscape by 600+ diseases and 35 tumors.
This means you can explore your insights like never before, empower better data driven decision making and achieve continual business growth.
Beyond product-level information, MIDAS can reveal trends at the level you need to proactively segment your market and prioritize new opportunities. Additional views include
IQVIA Analytics Link Ecosystem establishes deep connections across our key data assets.
Strengthen your portfolio by making more informed decisions and prepare for the impact of new research discoveries.
Measure the performance of your sales force and marketing channels, adapt your commercial strategy and gain real world competitive insights.
Access 470,000 products and nearly 40,000 drug profiles to analyze successful launch strategies and be ready for what’s next.
Track more than 60,000 pharmaceutical patent families across 130 countries to find opportunities and ensure timely business decisions.